Skip to search formSkip to main contentSkip to account menu

MGN1703

Known as: TLR9 Agonist MGN1703 
A synthetic oligonucleotide based on a proprietary double stem-loop immunomodulator design with potential immunostimulating activity. TLR9 agonist… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Maintenance therapy with a new immunomodulator agent called MGN1703 improves progression-free survival over placebo in patients…